These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 18847580)

  • 1. Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease.
    Suri V; Aggarwal N; Kaur R; Chaudhary N; Ray P; Grover A
    Contraception; 2008 Oct; 78(4):315-8. PubMed ID: 18847580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of side-effects of Cu-T as intra-uterine contraceptive device in post medical termination of pregnancy and interval cases.
    Das CR; Pradhan G
    J Indian Med Assoc; 1995 Oct; 93(10):375-6. PubMed ID: 9053409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of copper T as contraceptive after caesarean section.
    Parikh V; Gandhi AS
    J Indian Med Assoc; 1989 May; 87(5):113-5. PubMed ID: 2600433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cytologic studies of copper-IUD users.
    Engineer AD; Misra JS; Tandon P
    Acta Cytol; 1981; 25(5):550-6. PubMed ID: 6945020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experiences with the Medusa Cu 240 Ag intrauterine device].
    Girardi F
    Wien Klin Wochenschr; 1993; 105(24):728-31. PubMed ID: 8116311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrauterine contraception with copper-T 200 device- a retrospective analysis of 334 cases (author's transl)].
    Salzer H; Schneider WH; Eppel W
    Wien Klin Wochenschr; 1981 May; 93(11):354-8. PubMed ID: 7269615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The copper T380A intrauterine device in women with type II diabetes mellitus.
    Kjos SL; Ballagh SA; La Cour M; Xiang A; Mishell DR
    Obstet Gynecol; 1994 Dec; 84(6):1006-9. PubMed ID: 7970454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-year study of the copper-7 minigravigard intrauterine contraceptive device in nulliparous women.
    Srisupandit S
    J Med Assoc Thai; 1988 Jun; 71(6):294-7. PubMed ID: 3171448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconsidering IUDs.
    Goldberg B
    AVSC News; 1992 Jul; 30(2):7-8. PubMed ID: 12285571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
    Roy S; Azen C
    Am J Obstet Gynecol; 1994 Jun; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertion and removal of intrauterine devices.
    Johnson BA
    Am Fam Physician; 2005 Jan; 71(1):95-102. PubMed ID: 15663031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrauterine devices in general practice: a prospective study of 300 insertions].
    Marret H; Golfier F; Vollerin F; Legoaziou MF; Raudrant D
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):465-70. PubMed ID: 12379830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective, despite misconceptions. The IUD with progesterone must be replaced once a year, while the IUD with copper may be left in for up to 10 years.
    Indian Med Trib; 1996 Mar; 4(5):9. PubMed ID: 12179197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age.
    Bahamondes L; Faundes A; Sobreira-Lima B; Lui-Filho JF; Pecci P; Matera S
    Contraception; 2005 Nov; 72(5):337-41. PubMed ID: 16246658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The copper-7 intrauterine contraceptive device: 5-year evaluation.
    Sellors JW
    Can Med Assoc J; 1981 Oct; 125(7):717-20. PubMed ID: 7326653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of IUD and subsequent fertility--follow-up after participation in a randomized clinical trial.
    Hov GG; Skjeldestad FE; Hilstad T
    Contraception; 2007 Feb; 75(2):88-92. PubMed ID: 17241835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IUDs: current perspectives.
    Hepburn S
    Curr Ther (Seaforth); 1994 Oct; 35(10):49-55. PubMed ID: 12319352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate postplacental insertion of an intrauterine contraceptive device during cesarean section.
    Çelen Ş; Sucak A; Yıldız Y; Danışman N
    Contraception; 2011 Sep; 84(3):240-3. PubMed ID: 21843687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Our experience with Gyne-T Cu 380-A, an intrauterine contraceptive device (1983-1984)].
    Beric B; Aleksic S; Marjanovic M; Kranz F
    Contracept Fertil Sex (Paris); 1985 May; 13(5):717-9. PubMed ID: 12267100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.